{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:42:30Z","timestamp":1782294150759,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.diagmicrobio.2025.117105","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T06:48:43Z","timestamp":1757400523000},"page":"117105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of PNPLA3 genetic variants in Egyptian HBV-infected patients concomitant with metabolic-associated steatotic liver disease (MASLD)"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1023-8720","authenticated-orcid":false,"given":"Mai Abd","family":"El-Meguid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Salum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma E.","family":"Fotouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen Abdel","family":"Alem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0001","doi-asserted-by":"crossref","unstructured":"Degasperi E., Anolli M.P., Lampertico P. Towards a functional cure for Hepatitis B virus: a 2022 update on new antiviral strategies. 2022;14:2404.","DOI":"10.3390\/v14112404"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0002","doi-asserted-by":"crossref","unstructured":"McGlynn K.A., Petrick J.L., El-Serag H.B.J.H. Epidemiology of hepatocellular carcinoma. 2021;73:4-13.","DOI":"10.1002\/hep.31288"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0003","doi-asserted-by":"crossref","unstructured":"Zhang Ch, Cheng Y., Zhang S., Fan J., Gao Q.J.L.I. Changing epidemiology of hepatocellular carcinoma in Asia. 2022;42:2029-41.","DOI":"10.1111\/liv.15251"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0004","first-page":"12","article-title":"Global perspectives on the Hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030","author":"Al-Busafi","year":"2024","journal-title":"Vaccines. (Basel)"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Correction Naghavi","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0006","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2014.05.045","article-title":"Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection","volume":"61","author":"Spradling","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0007","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.21037\/atm-21-3052","article-title":"Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis","volume":"9","author":"Jiang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0008","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0009","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.dld.2024.11.002","article-title":"Mortality risk associated with MASLD, MASLD type and different cardiometabolic risk factors in IBD patients: a long-term prospective cohort study","volume":"57","author":"Zhang","year":"2025","journal-title":"Digest. Liver Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091239","article-title":"PNPLA3 rs738409 Polymorphism predicts development and severity of hepatic steatosis but not metabolic syndrome in celiac disease","volume":"10","author":"Tortora","year":"2018","journal-title":"Nutrients."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0012","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104805","article-title":"Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians","volume":"153","author":"Dawood","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156714","article-title":"Evaluation of the expression of fibrosis-related genes as non-invasive diagnostic biomarkers for cirrhotic HCV-infected patients","volume":"182","author":"El-Meguid","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0015","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1038\/s41598-024-60152-0","article-title":"Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0016","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-0035-1567870","article-title":"Insights from genome-wide Association analyses of nonalcoholic fatty liver disease","volume":"35","author":"Kahali","year":"2015","journal-title":"Semin. Liver. Dis."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1290842","article-title":"Non-alcoholic fatty liver disease related knowledge among a sample of Egyptians: an exploratory cross-sectional study","volume":"11","author":"Hegazy","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16123","article-title":"Global epidemiological impact of PNPLA3 I148M on liver disease","volume":"45","author":"Kozlitina","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0019","doi-asserted-by":"crossref","DOI":"10.21608\/fsrt.2020.23438.1009","article-title":"PNPLA3 and GCKR gene polymorphisms influence genetic susceptibility to NAFLD in Obese Egyptians","author":"mahmoud","year":"2020","journal-title":"Front. Scientif. Res. Technol"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0020","doi-asserted-by":"crossref","unstructured":"Tilson S.G., Morell C.M., Lenaerts A.S., Park S.B., Hu Z., Jenkins B., et al. Modeling PNPLA3-associated NAFLD using Human-induced pluripotent stem cells. 2021;74:2998-3017.","DOI":"10.1002\/hep.32063"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0021","doi-asserted-by":"crossref","unstructured":"Govaere O., Cockell S., Tiniakos D., Queen R., Younes R., Vacca M., et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. 2020;12:eaba4448.","DOI":"10.1126\/scitranslmed.aba4448"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0022","doi-asserted-by":"crossref","unstructured":"Loomba R., Friedman S.L., Shulman GIJC. Mechanisms and disease consequences of nonalcoholic fatty liver disease. 2021;184:2537-64.","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a8523212-5e34-4475-93d3-9e90021ebb03","article-title":"The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation","volume":"7","author":"Krarup","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4216451","article-title":"Interplay of PNPLA3 and HSD17B13 variants in modulating the risk of hepatocellular carcinoma among hepatitis C patients","volume":"2020","author":"De Benedittis","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0025","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0026","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0027","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0028","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/ijms21093089","article-title":"Possible relevance of PNPLA3 and TLL1 gene polymorphisms to the efficacy of PEG-IFN therapy for HBV-infected patients","volume":"21","author":"Enomoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0029","doi-asserted-by":"crossref","first-page":"e3001","DOI":"10.1002\/jgm.3001","article-title":"Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: systematic review with meta-analysis","volume":"20","author":"Ghalamkari","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0031","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2017.74","article-title":"PNPLA3 and obesity: a synergistic relationship in NAFLD","volume":"14","author":"Mann","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0032","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.18943","article-title":"Correlation between patatin-like phospholipase domain-containing protein 3 gene polymorphisms and liver cirrhosis in a chinese han population with chronic hepatitis B","volume":"14","author":"Tong","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0033","doi-asserted-by":"crossref","unstructured":"Ghalamkari S., Sharafi H., Alavian S.M. Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: systematic review with meta-analysis. 2018;20:e3001.","DOI":"10.1002\/jgm.3001"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0034","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1007\/s10620-015-3716-7","article-title":"Patatin-like phospholipase domain-containing 3 I148M variant is associated with liver steatosis and fat distribution in chronic Hepatitis B","volume":"60","author":"Zampino","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0035","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2024.0837","article-title":"Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B","volume":"31","author":"Zhang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0036","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2147\/DMSO.S369824","article-title":"Association between metabolic dysfunction-associated fatty liver disease and the risk of cirrhosis in patients with chronic Hepatitis B-A retrospective cohort study","volume":"15","author":"Wang","year":"2022","journal-title":"Diabetes, Metabol. Syndrome Obesity"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144585","article-title":"PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: a case-control study and meta-analysis on Asians","volume":"742","author":"Wang","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0038","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/apt.15830","article-title":"Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices","volume":"52","author":"Younossi","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102495","article-title":"Global epidemiology and implications of PNPLA3 I148M variant in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"15","author":"Souza","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0040","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.3748\/wjg.v21.i28.8605","article-title":"Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B","volume":"21","author":"Pan","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0041","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.34790","article-title":"Predictive factors in the incidence of cirrhosis in chronic Hepatitis B Virus infections","volume":"16","author":"Alavian","year":"2016","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0042","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijid.2014.08.005","article-title":"Historic and current hepatitis B viral DNA and quantitative HBsAg level are not associated with cirrhosis in non-Asian women with chronic hepatitis B","volume":"29","author":"Harkisoen","year":"2014","journal-title":"Int. J. Infect. Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0043","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cgh.2009.09.026","article-title":"Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis","volume":"8","author":"Kim","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0044","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/S1678-9946201658065","article-title":"ADVANCED LIVER INJURY IN PATIENTS WITH CHRONIC HEPATITIS B AND VIRAL LOAD BELOW 2,000 IU\/mL","volume":"58","author":"Oliveira","year":"2016","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jvh.12766","article-title":"Inverse relationship between hepatic steatosis and hepatitis B viremia: results of a large case-control study","volume":"25","author":"Hui","year":"2018","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0046","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1440-1746.2012.07268.x","article-title":"Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model","volume":"27","author":"Zhang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0047","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","article-title":"Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients","volume":"26","author":"Machado","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0048","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00535-019-01594-6","article-title":"Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population","volume":"54","author":"Wang","year":"2019","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0049","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12072-018-9877-7","article-title":"Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model","volume":"12","author":"Hu","year":"2018","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0050","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1440-1746.2008.05531.x","article-title":"Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection","volume":"23","author":"Jp","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101155","article-title":"NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: a multi-center, retrospective study","volume":"29","author":"Yao","year":"2024","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0052","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2020.05.040","article-title":"Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B","volume":"73","author":"Mak","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.diagmicrobio.2025.117105_bib0053","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/jvh.13361","article-title":"Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B","volume":"27","author":"Wong","year":"2020","journal-title":"J. Viral. Hepat."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325004274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325004274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:03:21Z","timestamp":1769519001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325004274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0732889325004274"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117105","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of PNPLA3 genetic variants in Egyptian HBV-infected patients concomitant with metabolic-associated steatotic liver disease (MASLD)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117105"}}